Hospira names Zena Kaufman senior VP of quality
This article was originally published in Scrip
Hospira, a leading provider of injectable drugs and infusion technologies, has appointed Zena Kaufman senior vice-president of quality, effective 27 February 2012. Ms Kaufman will report to F Michael Ball, Hospira's CEO. She most recently served as divisional vice-president of global quality systems and global pharmaceutical operations for Abbott Laboratories. She currently serves on the board of the Parental Drug Association, and was previously a representative of PhRMA.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.